Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Custirsen + Gemcitabine/Platinum in Advanced NSCLC
NCT00138658Phase 2Completed
- Sponsor
- Achieve Life Sciences
- Start
- Nov 2004
- Primary completion
- Mar 2010
- Modality
- Small Interfering RNA (siRNA), Modified DNA Oligonucleotides, Single-strand DNA
- Countries
- 2
01
Overview
A Phase 2 trial of custirsen in non-small cell lung cancer (NSCLC), sponsored by Achieve Life Sciences. Started Nov 2004; status: completed.
02
Drugs
custirsen
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00138658.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00138658.